We do not offer telephone consultations. Please contact us via email or live chat.
© 2026 Together Clinic
All Treatments
Five prescription treatments, one clinical standard. Every assessment is reviewed by a UK-registered independent prescriber — and nothing is charged unless they approve.
Enter your height and weight for an instant, private indication. Nothing is stored.
An indication only. Thresholds are lower for some ethnic backgrounds, and the full assessment accounts for this. A prescriber makes the final decision.
Choose Your Treatment
All prescribed by UK-registered independent prescribers after a full clinical review.
Once weekly. The highest average weight loss in clinical trials.
22.5% average weight loss
Dual-action GLP-1 and GIP receptor agonist, taken once a week. Up to 22.5% body weight reduction in clinical trials.
20.7% average weight loss
GLP-1 receptor agonist with proven cardiovascular benefits. Up to 20.7% body weight reduction and 20% reduced cardiovascular risk.
Once daily, needle-free.
Up to 16.6% average weight loss
A once-daily oral form of semaglutide — the same active ingredient as Wegovy® injection — for adults who prefer a needle-free option for weight management.
from £99
No fasting rules
Orforglipron — the first non-peptide GLP-1 tablet licensed in the UK. Once daily, taken with or without food, with no waiting period before you eat.
from £99
Branded as Xenical
A clinically proven weight loss tablet that reduces the amount of fat your body absorbs from food. Suitable for patients with a Body Mass Index (BMI) of 28 or above.
Compare Treatments
Once-daily, needle-free options.
| Foundayo | Wegovy Tablets | |
|---|---|---|
| Active Ingredient | Orforglipron | Semaglutide |
| How It's Taken | Any time, with or without food | Empty stomach, 30 min before food |
| Dose Strengths | Six (0.8mg – 17.2mg) | Four (1.5mg – 25mg) |
| Dosing Plan | Minimum 30 days per step | Four tablet strengths |
| Delivery | Tracked & discreet | Tracked & discreet |
| Side Effects | Nausea, diarrhoea, reduced appetite | Nausea, diarrhoea, reduced appetite |
Once-weekly, with the highest average weight loss in clinical trials.
| Mounjaro | Wegovy | |
|---|---|---|
| Active Ingredient | Tirzepatide | Semaglutide |
| Weight Loss | Up to 22.5% | Up to 20.7% |
| How It's Taken | Once-weekly injection | Once-weekly injection |
| Starting Dose | 2.5mg | 0.25mg |
| Dosing Plan | 20 weeks to full dose | 16 weeks to full dose |
| Delivery | Tracked & discreet | Tracked & discreet |
| Side Effects | Nausea, diarrhoea, reduced appetite | Nausea, diarrhoea, reduced appetite |
Not sure which is right for you? Complete the screening assessment and a UK-registered prescriber will recommend the most appropriate option.
Simple, safe, supervised
Every assessment is reviewed by a UK-registered prescriber before anything is prescribed. Personalised treatment, ongoing support, delivered to your door.
Answer a few questions about your health and what you need, in our secure online form.
One of our independent pharmacist prescribers reviews your assessment in full — and may contact you for more information — before any treatment is prescribed.
Your treatment arrives discreetly packaged, with guidance materials and support from our pharmacy team.
Nothing is charged until a prescriber approves your treatment.